Showing results (1-10 of 114) with videos related to
Sort By:
Pageof 12
Urologia|October 5, 2010
[Antibiotic prophylaxis in prostate biopsy]V Serretta, A Catanese, A Ruggirello, et al.Prostate Cancer and Prostatic Diseases|July 20, 2007
PSA reduction (after antibiotics) permits to avoid or postpone prostate biopsy in selected patientsV Serretta, A Catanese, G Daricello, et al.Urologia Internationalis|August 5, 2006
Preliminary report of a multicentric study on environmental risk factors in Ta-T1 transitional cell carcinoma of the bladder. A study from Gruppo Studi Tumori Urologici FoundationV Serretta, G Morgia, V Altieri, et al.Urologia Internationalis|April 24, 2001
PSA and second-line therapy of hormone refractory prostate carcinomaV Serretta, I Rizzo, G Contino, et al.Urologia|November 19, 2010
[Management, and prevention, of intravesical therapy complications]V SerrettaOncology Reports|May 21, 2011
Idarubicin in the intravesical treatment of superficial transitional-cell carcinoma of the bladder (ta-t1) - a phase I-ii studyV Serretta, S Piazza, P Vasile, et al.Seminars in Oncology|April 1, 1992
The role of epipodophyllotoxin derivatives in bladder cancerV Serretta, G B Ingargiola, M Pavone-MacalusoEuropean Urology|October 12, 2000
Urinary BTA-stat, BTA-trak and NMP22 in surveillance after TUR of recurrent superficial transitional cell carcinoma of the bladderV Serretta, G Pomara, I Rizzo, et al.European Urology|February 15, 2000
Pure squamous cell carcinoma of the bladder in western countries. Report on 19 consecutive casesV Serretta, G Pomara, F Piazza, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Intravesical mitoxantrone in superficial bladder tumours (Ta-T1)V Serretta, G Corselli, C Pavone, et al.Pageof 12